ROSEN Law Firm Encourages Soleno Therapeutics Investors to Seek Legal Counsel

The top-ranked firm is investigating potential securities claims on behalf of Soleno Therapeutics shareholders.

Mar. 29, 2026 at 6:29am

Got story updates? Submit your updates here. ›

ROSEN, a globally recognized law firm, is encouraging investors in Soleno Therapeutics, Inc. to seek legal representation as the firm investigates potential securities claims on their behalf. The investigation focuses on Soleno Therapeutics' business practices and disclosures to shareholders.

Why it matters

Soleno Therapeutics is a biopharmaceutical company developing treatments for rare diseases. Any potential legal issues or securities claims could significantly impact the company's operations and shareholder value.

The details

ROSEN, a leading global law firm, is proactively investigating potential securities claims on behalf of Soleno Therapeutics shareholders. The investigation is focused on the company's business practices and disclosures to investors. ROSEN is urging Soleno Therapeutics shareholders to contact the firm to discuss their legal options.

  • The investigation was announced on March 28, 2026.

The players

ROSEN

A globally recognized law firm that specializes in representing investors in securities litigation.

Soleno Therapeutics, Inc.

A biopharmaceutical company developing treatments for rare diseases.

Got photos? Submit your photos here. ›

What they’re saying

“We encourage investors to contact us to discuss their legal options.”

— Laurence Rosen, Managing Partner, ROSEN Law Firm

What’s next

ROSEN is urging Soleno Therapeutics shareholders to contact the firm to discuss their legal options and potential next steps.

The takeaway

This investigation highlights the importance for investors to closely monitor the business practices and disclosures of the companies they invest in, and to seek legal counsel if they have concerns about potential securities violations.